Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy science biotech

	Profile	Recent Articles on Subject
1	Michael Corris Artforum	THE POLITICS OF CARE - 4 months ago
2	Ed Cara Gizmodo	5 Real Medical Treatments That Sound Like Sci-Fi - 5 months ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 5 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 5 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 5 months ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - 5 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - 5 months ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - 6 months ago STAT+: Pharmalittle: AMA calls for obesity drug coverage; Covid rebound may be more common with Paxlovid than without - 6 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - 6 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 6 months ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - 6 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 8 months ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - 8 months ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - 8 months ago
4	Anne Thomas Hooper, PharmD candidate 2024 Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
5	Maddie Cheak, PharmD candidate 2024 Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
6	Marilyn Bulloch, PharmD, BCPS Pharmacy Times	Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023 - 5 months ago
7	Tom Vanderbilt Wired	You Know It’s a Placebo. So Why Does It Still Work? - 5 months ago
8	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	Doc's Xmas Wish List; Derms at the Beach; The 'Arrival Fallacy' in Medicine - 5 months ago
9	Kate Kneisel MedPage Today	Doc's Xmas Wish List; Derms at the Beach; The 'Arrival Fallacy' in Medicine - 5 months ago
10	Donald Levick, MD, MBA Pharmacy Times	Improving Medication Guidance Needs to be a Top Priority for Hospitals, Health Systems - 5 months ago

Journalists covering medicine